Kidney Disease Clinical Trials

Showing 1521-1540 of 3,902 trials

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

NCT05875948

This study aims to evaluate the safety, tolerability and efficacy of R2R01 combined with terlipressin as compared to terlipressin alone in the treatment of patients with HRS-AKI

Hepatorenal SyndromeAcute Kidney Injury

River 2 Renal Corp.95 participantsStarted Jun 2023

San Francisco, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +4 more locations

COMPLETEDPhase 1

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

NCT05611957

The main purpose of this study is to assess the amount of study drug that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment compared to healthy participants. The study will last up to 5 weeks, excluding screening.

HealthyRenal Insufficiency

Eli Lilly and Company29 participantsStarted Nov 2022

Tustin, California, United States • Miami, Florida, United States • Orlando, Florida, United States +1 more locations

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function

Related Searches

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

A Phase 3 Study of Bardoxolone Methyl in Patients With Diabetic Kidney Disease; AYAME Study

Effects of Intradialytic Aerobic Exercise in Chronic Kidney Patients

Dietary Acid Load, Kidney Function and Disability in Elderly

Effect of Ketogenic Diet on Peri-operative Complications of Right Laparoscopic Adrenalectomy in Obese Patients

Hemostatic Profiles in Pediatric CKD

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device

The Effect of Etelcalcetide on CKD-MBD

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

Phase II Study of Alternating Sunitinib and Temsirolimus

A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis

Peer Support In Dialysis

Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Vascular Changes Following Forearm Loop Arteriovenous Graft Placement